Patient information: uses, side effects, how to take - Mimrylo
What is MIMRYLO?
MIMRYLO is a prescription medicine that is used to treat erythrocytosis (high red blood cell count) in adults with polycythemia vera.
It is not known if MIMRYLO is safe and effective in children.
Before using MIMRYLO, tell your healthcare provider about all of your medical conditions, including if you:
are pregnant or plan to become pregnant. MIMRYLO may harm your unborn baby.
Females who are able to become pregnant:
- Your healthcare provider may do a pregnancy test before you start treatment with MIMRYLO.
- Use effective birth control (contraception) during treatment and for at least 30 days after the final dose of MIMRYLO.
- Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with MIMRYLO.
- Stop taking MIMRYLO if you become pregnant.
- are breastfeeding or plan to breastfeed. It is not known if MIMRYLO passes into your breast milk. Do not breastfeed during treatment with MIMRYLO and for 30 days after the final dose of MIMRYLO. Talk to your healthcare provider about the best way to feed your baby during this time.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How should I use MIMRYLO?
- See the detailed Instructions for Use that comes with MIMRYLO for information on how to prepare and inject a dose of MIMRYLO.
- Use MIMRYLO exactly as your healthcare provider tells you to.
- Your healthcare provider will tell you how much MIMRYLO to inject and when to inject it. Do not inject more than your prescribed dose.
- Do not change your dose or stop treatment with MIMRYLO unless your healthcare provider tells you.
- MIMRYLO is given as an injection under your skin (subcutaneous injection).
- Inject MIMRYLO under the skin in the stomach area (abdomen) at least 2 inches away from the belly button (navel), front of the thigh, or the upper outer arm. Choose a different site each time you inject MIMRYLO.
- Your healthcare provider should show you or your caregiver how to prepare and inject MIMRYLO. Contact your healthcare provider if you have questions. Do not inject yourself or someone else until you have been shown how to inject MIMRYLO.
- MIMRYLO is available in more than 1 strength. Make sure the MIMRYLO strength you have matches your prescribed strength.
Your prescribed dose may require more than 1 injection.
- Do not give more than two injections a day.
- If your weekly dose is greater than 82 mg, give your first injection on day 1 and the second injection on day 4 or 5.
If you inject one time a week:
- If you miss a dose by 1 to 4 days, take the missed injection as soon as you remember. Then continue with your regular weekly schedule.
- If you miss a dose by more than 4 days, take the missed injection as soon as you remember. Take your next injection 3 days later and then return to your regular weekly schedule.
If you inject two times a week:
- If you miss a dose by 1 to 2 days, take the missed injection as soon as you remember. Take your next injection 3 days later and then return to your regular schedule.
- If you miss a dose by more than 2 days, skip the dose and continue with your regular injection schedule.
- Contact your healthcare provider if you do not know when to inject a missed dose.
What are the possible side effects of MIMRYLO?
MIMRYLO may cause serious side effects, including:
- New or worsening increased blood platelets (thrombocytosis). MIMRYLO may increase blood platelet counts. Your healthcare provider will do blood tests when you start and during treatment with MIMRYLO to check your platelet counts.
- Injection-site reactions. MIMRYLO may cause injection-site reactions such as redness, itching, pain, swelling, bruising, hardening at the injection site, and irritation. If you get an injection site reaction, apply ice packs, steroid cream, or take medicines as needed to treat injection site pain and swelling.
Your healthcare provider may change your dose or stop treatment with MIMRYLO if you have side effects.
The most common side effects of MIMRYLO are:
- injection site reactions
- low red blood cell count (anemia)
These are not all of the possible side effects of MIMRYLO.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store MIMRYLO?
- Store MIMRYLO at room temperature between 68°F to 77°F (20°C to 25°C).
- Do not freeze.
- Store MIMRYLO in the original carton to protect it from light.
- Do not use the vial or diluent syringe after the expiration date on the carton.
- After mixing (reconstitution), MIMRYLO may be stored at room temperature between 68°F to 77°F (20°C to 25°C) for up to 4 hours.
- Use MIMRYLO within 4 hours after mixing.
- Throw away (dispose of) mixed MIMRYLO if not used within 4 hours.
Keep MIMRYLO and all medicines out of the reach of children.
General information about the safe and effective use of MIMRYLO.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use MIMRYLO for a condition for which it was not prescribed. Do not give MIMRYLO to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about MIMRYLO that is written for health professionals.
What are the ingredients in MIMRYLO?
Active ingredient: rusfertide acetate
Inactive ingredients: mannitol, sodium acetate trihydrate, and glacial acetic acid/sodium hydroxide for pH adjustment.
The diluent for MIMRYLO contains sodium acetate trihydrate, zinc acetate dihydrate, and glacial acetic acid.
Distributed by:
Takeda Pharmaceuticals America, Inc.,
Cambridge, MA 02142
MIMRYLO is a trademark of Takeda Pharmaceuticals U.S.A., Inc.
TAKEDA and are registered trademarks of Takeda Pharmaceutical Company Limited.
©2026 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved.
For more information, go to www.MIMRYLO.com or call 1-877-TAKEDA-7 (1-877-825-3327).
INSTRUCTIONS FOR USE MIMRYLO™ (mim-rahy-loh) (rusfertide) for injection, for subcutaneous use |
This Instructions for Use contains information on how to prepare and inject MIMRYLO.
Read this Instructions for Use before you begin preparing and injecting MIMRYLO and each time you get a refill. There may be new information.
Your healthcare provider should show you or your caregiver how to prepare and inject MIMRYLO. Do not inject yourself or someone else until you have been shown how to inject MIMRYLO.
Available Strengths

Supplies Needed to Inject MIMRYLO (Figure A)
Supplies Included in the MIMRYLO Carton

Additional Supplies (not included in the carton)
![]() |
| Figure A |
If you do not have these items, ask your pharmacist.
Important Information You Need to Know Before Preparing and Injecting MIMRYLO
- For injection under the skin (subcutaneous injection) only.
- MIMRYLO is available in more than 1 strength. Make sure the MIMRYLO strength you have matches your prescribed strength.
- If you have any questions on preparing or injecting MIMRYLO, contact your healthcare provider.
Your prescribed dose may require more than 1 injection.
- Do not administer more than two injections daily.
- If your weekly dosage is greater than 82 mg, administer your first injection on day 1 and the second injection on day 4 or 5.
- The supplies included in the MIMRYLO carton, vial adapter, needle, and alcohol swabs are for single use only. Do not reuse any of these supplies.
- Do not use if any of the supplies are opened, damaged, or missing.
- Do not use if MIMRYLO is expired.
- MIMRYLO is supplied as a single-dose vial of powder for mixing (reconstitution). Before you inject MIMRYLO, you must mix (reconstitute) MIMRYLO with liquid (diluent) that comes in a syringe.
- Do not prepare MIMRYLO for injection until you are ready to inject. Keep the medicine at room temperature after mixing (see Storing MIMRYLO). Inject MIMRYLO within 4 hours of mixing.
- Do not touch the gray rubber stopper on the top of the vial.
- Do not let the vial adapter tip or spike touch your hands or any surface.
- Do not let the syringe tip or needle touch your hands or any surface.
- Do not throw away the needle or syringe in your household trash. See “After Injecting MIMRYLO” section below for more information.
- This product is not made with natural rubber latex.
Storing MIMRYLO
- Store the MIMRYLO at room temperature between 68° to 77°F (20° to 25°C) (Figure B).
- Do not freeze.
- Store MIMRYLO in the original carton to protect it from light.
- Do not use the vial or diluent syringe after the expiration date on the carton.
- After mixing, MIMRYLO may be stored at room temperature between 68° to 77°F (20° to 25°C) for up to 4 hours.
- Use MIMRYLO within 4 hours after mixing.
- Throw away (dispose of) the mixed MIMRYLO if not used within 4 hours.
Keep MIMRYLO and all medicines out of the reach of children.
![]() |
| Figure B |
Getting Started
1 Washing hands and checking the supplies
1.1 Wash hands well with soap and water (Figure C).
![]() |
| Figure C |
1.2 Check your prescribed dose (Figure D). MIMRYLO is available in more than 1 strength. Your prescribed dose may require more than 1 injection.
1.3 Check the expiration date on the outside of the carton (Figure D).
![]() |
| Figure D |
Do not use MIMRYLO if the expiration date has passed and contact your healthcare provider.
1.4 Take all items out of the carton. Remove the prefilled syringe by the body only.
Do not remove the diluent syringe from the carton by its plunger rod or syringe cap.
1.5 Check if the supplies have been opened, damaged, or are missing (Figure E).
Do not use if any of the supplies are opened, damaged or missing.
![]() |
| Figure E |
1.6 Gather additional supplies (Figure F).
![]() |
| Figure F |
Preparing MIMRYLO for Injection (Reconstitution)
2 Attaching the vial adapter to the medicine vial
2.1 Take off the cap from the medicine vial (Figure G).
Throw away the medicine vial cap into household trash.
![]() |
| Figure G |
2.2 Clean gray rubber stopper on top of the medicine vial with a new alcohol swab (Figure H).
Throw away used alcohol swab into household trash.
Do not touch the gray rubber stopper on the top of the vial after cleaning.
![]() |
| Figure H |
2.3 Open vial adapter packaging (Figure I).
- Do not let the vial adapter spike touch your hands or any surface.
- Do not remove the vial adapter from its plastic packaging.
Note: Your vial adapter may look different. Follow the vial adapter manufacturer instructions.
![]() |
| Figure I |
2.4 Place the medicine vial on a flat surface. Hold (stabilize) the medicine vial with 1 hand. Using the other hand place the vial adapter in its packaging over the medicine vial.
Push the adapter straight down onto the top of the medicine vial until it snaps on and is fully attached (Figure J).
Note: The spike on the vial adapter should punch through (puncture) the gray rubber stopper.
- Do not attach the vial adapter at an angle.
- Do not remove the vial adapter from the medicine vial after it is attached.
![]() |
| Figure J |
3 Attaching the diluent syringe to the vial adapter
3.1 Lightly squeeze the plastic packaging to lift and remove it from the vial adapter (Figure K).
Throw away the plastic packaging into household trash.
Do not let the vial adapter tip touch your hands or any surface.
![]() |
| Figure K |
3.2 Take off the diluent syringe cap (Figure L):
- hold the syringe by the body with 1 hand
- with the other hand, remove the syringe cap by turning to the left (counterclockwise) until it lifts away.
Throw away the syringe cap into household trash.
Do not let the diluent syringe tip touch your hands or any surface.
![]() |
| Figure L |
3.3 Attach the diluent syringe to the vial adapter (Figure M):
- place the medicine vial on a flat surface
- hold the vial adapter with 1 hand
- with the other hand attach the diluent syringe to the vial adapter by turning to the right (clockwise) until it is snug.
Do not tighten too much.
![]() |
| Figure M |
4 Mixing the diluent with the powdered medicine
4.1 Place the medicine vial on a flat surface with the diluent syringe pointing down.
Inject all the diluent into the medicine vial by slowly pushing down on the diluent syringe plunger rod until it is empty (Figure N).
Do not remove the diluent syringe from the medicine vial.
![]() |
| Figure N |
4.2 Mix the diluent and medicine by slowly and gently swirling the medicine vial in a circular motion until the powder is fully dissolved. This may take about 2 minutes (Figure O).
If there is powder medicine stuck to the inside of the medicine vial wall, continue to gently swirl until it is removed.
The mixed medicine may look foamy.
Do not shake the medicine vial.
![]() |
| Figure O |
4.3 Set the medicine vial with the attached diluent syringe on a clean flat surface and let it sit to allow the liquid to settle and any excess foam to go away. This may take about 1 minute (Figure P).
The diluent syringe plunger rod may rise up by itself. This is normal.
![]() |
| Figure P |
4.4 After the liquid has settled, inspect the liquid (Figure Q).
It should be clear with very little foam, colorless, and free from visible particles.
Important: You must inject the medicine within 4 hours of mixing it.
Do not use the medicine vial if the liquid looks colored or contains particles.
![]() |
| Figure Q |
5 Drawing the mixed (reconstituted) medicine into the syringe
5.1 Make sure the syringe plunger rod is pressed down all the way to remove any air (Figure R).
![]() |
| Figure R |
5.2 While holding the plunger down, turn the syringe upside down so the medicine vial is now on top (Figure S).
![]() |
| Figure S |
5.3 Hold the syringe with the medicine vial on top. Slowly pull the syringe plunger rod down to fill the syringe with the mixed medicine (Figure T).
Note: It is normal to have an air gap or bubbles in the syringe after drawing liquid.
![]() |
| Figure T |
6 Taking the empty medicine vial off the syringe
6.1 Take off the empty medicine vial (Figure U):
- hold the syringe by the body with 1 hand
- with the other hand, grasp the vial adapter and remove the vial adapter by turning to the left (counterclockwise) until it lifts away.
- Do not touch the syringe tip or allow it to touch any surface.
- Do not touch or push the plunger rod until you are ready to inject.
![]() |
| Figure U |
6.2 Throw away (dispose of) the empty medicine vial into an FDA-cleared sharps disposal container (Figure V).
See the “Additional Disposal Information” section below for more information.
Do not throw away (dispose of) the empty medicine vial in your household trash.
![]() |
| Figure V |
Injecting MIMRYLO
7 Attaching the needle to the syringe
7.1 Remove the needle from its packaging by using your fingers to pull the package apart (Figure W).
Do not touch the open end of the needle.
Note: Your needle may look different. Follow the needle manufacturer instructions.
![]() |
| Figure W |
7.2 Attach the needle to the syringe (Figure X):
- hold the syringe by the body with 1 hand
- with the other hand attach the needle onto the syringe by turning to the right (clockwise) until it is snug.
![]() |
| Figure X |
7.3 Set the prepared syringe on a clean flat surface (Figure Y).
Important: You must inject the medicine within 4 hours of mixing it.
Do not touch or push the plunger rod until you are ready to inject.
![]() |
| Figure Y |
8 Choosing and cleaning the injection site(s)
8.1 Choose from the following injection sites (Figure Z):
![]() |
| Figure Z |
- Do not select a site where the skin is tender, bruised, red, irritated, hard or broken.
- Do not inject into the same spot twice in a row. Change (rotate) sites between injections. You can write down or log your injection sites to help remember.
8.2 Clean the chosen injection site(s) with a new alcohol swab. Allow the skin to air dry (Figure AA).
Throw away used alcohol swab into household trash.
- Do not touch the cleaned area again before injecting.
- Do not fan or blow on the clean site.
![]() |
| Figure AA |
9 Taking off the needle cap
9.1 Hold the syringe by the body with the needle pointing up. Pull the needle shield back (Figure AB).
Do not remove the needle shield from the needle.
![]() |
| Figure AB |
9.2 Carefully take off the needle cap by holding the syringe by the body with 1 hand and firmly pulling the cap straight off with the other hand (Figure AC).
Throw away the needle cap into household trash.
- Do not touch the plunger rod while taking off the needle cap.
- Do not use if the needle looks damaged or bent.
- Do not let the needle touch your hands or any surface.
- Do not use if the syringe is dropped without the needle cap on.
![]() |
| Figure AC |
10 Removing air from the syringe
10.1 Hold the syringe with the needle tip pointing straight up (Figure AD).
10.2 Tap the syringe with your finger to move any air or bubbles to the syringe tip (Figure AD).
10.3 Slowly and carefully push the syringe plunger rod to remove the air or bubbles.
It is okay if a small air gap or bubbles are left in the syringe.
![]() |
| Figure AD |
11 Giving the Injection
11.1 Use 1 hand to pinch the skin at the injection site (Figure AE).
This allows you to insert the needle into the fatty tissue just under the skin (subcutaneous injection).
![]() |
| Figure AE |
11.2 Insert the needle into the pinched skin at a 45 to 90 degree angle (Figure AF).
The pinched skin can be released after the needle is inserted.
![]() |
| Figure AF |
11.3 Slowly push the plunger rod to inject all the medicine (Figure AG).
After all the medicine is injected, pull the needle and syringe out of the skin at the same angle as you inserted it.
![]() |
| Figure AG |
After Injecting MIMRYLO
12 Throwing away (disposing of) the syringe and needle into sharps disposal container and treating the injection site
12.1 Right after injection of the medicine, place the needle shield on the hard surface to carefully push the needle shield over the needle until it snaps into place and covers the needle (Figure AH and AI).
- Do not try to remove the needle from the syringe.
- Do not recap or touch the needle.
![]() |
| Figure AH |
![]() |
| Figure AI |
12.2 Throw away (dispose of) the used syringe with the needle attached into an FDA-cleared sharps disposal container (Figure AJ).
Do not throw away (dispose of) the needle or syringe in your household trash.
![]() |
| Figure AJ |
12.3 If there is bleeding at the injection site, gently press a cotton ball or gauze pad over the site (Figure AK) and hold for 10 seconds. Cover with an adhesive bandage if needed.
Do not rub the injection site.
![]() |
| Figure AK |
12.4 If your dosage requires two injections, repeat steps 1 through 12.
- If your weekly dosage is greater than 82 mg, administer your first injection on day 1 and the second injection on day 4 or 5.
Additional Disposal Information
FDA-cleared sharps disposal containers are generally available through pharmacies, medical supply companies, healthcare providers, and online.
If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:
- made of a heavy-duty plastic,
- can be closed with a tight-fitting, puncture-resistant lid without sharps being able to come out,
- upright and stable during use,
- leak-resistant, and
- properly labeled to warn of hazardous waste inside the container.
When your sharps disposal container is almost full, you will need to follow community guidelines for the right way to throw away (dispose of) your sharps disposal container.
There may be state or local laws about how you should throw away used vials, needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at: http://www.fda.gov/safesharpsdisposal .
Do not throw away (dispose of) your used sharps disposal container in your household trash unless your community guidelines permit this.
Do not recycle your used sharps disposal container.
Keep the sharps disposal container out of the reach of children.
Additional Information
For more information about how to prepare and inject with MIMRYLO visit www.MIMRYLO.com or call 1-877-TAKEDA-7 (1-877-825-3327).
Distributed by:
Takeda Pharmaceuticals America, Inc.
Cambridge, MA 02142
MIMRYLO and are trademarks of Takeda Pharmaceuticals U.S.A., Inc.
TAKEDA and are registered trademarks of Takeda Pharmaceutical Company Limited.
©2026 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved.
This Instructions for Use has been approved by the U.S. Food and Drug Administration. Approved: August 2026





































